SCHEMBL4730362

SCHEMBL4730362

O=C(O)N1CCOC(c2ccccc2)C1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 2/20 0.55
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
CNR2 P34972 4/20 0.45
TSHR P16473 1/20 0.42
RIPK1 Q13546 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
RAB9A P51151 2/20 0.40
DRD3 P35462 1/20 0.40
NUDT1 P36639 1/20 0.40
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ALDH1A1 P00352 1/20 0.40
POLB P06746 1/20 0.40
PDE2A O00408 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
GSK3B P49841 1/20 0.39
MOGAT2 Q3SYC2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4730357 1.00 USP30 (0.55) USP30MEN1KMT2ACNR2TSHR
SCHEMBL14413642 0.89 USP30 (0.54) USP30MEN1KMT2ACNR2TSHR
SCHEMBL19049384 0.87 USP30 (0.54) USP30MEN1KMT2ACNR2TSHR
SCHEMBL25453440 0.87 USP30 (0.54) USP30MEN1KMT2ACNR2TSHR
SCHEMBL3790233 0.87 USP30 (0.44) USP30MEN1KMT2ADRD3ALDH1A1
SCHEMBL27875627 0.87 USP30 (0.44) USP30MEN1KMT2ADRD3ALDH1A1
SCHEMBL502854 0.86 USP30 (0.44) USP30MEN1KMT2AL3MBTL1DRD3
SCHEMBL3375071 0.86 USP30 (0.44) USP30RAB9ANPC1TP53SMN1; SMN2
SCHEMBL14150546 0.86 USP30 (0.46) USP30MEN1KMT2ACNR2DRD3
SCHEMBL3370271 0.86 MEN1 (0.49) USP30MEN1KMT2ACNR2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108440515-A Substituted benzofuranyl and benzoxazole based compound and application thereof 卡尔约药物治疗公司 2018-08-24 CN disclosed
CN-105492437-B Substituted benzofuranyl and benzoxazolyl compounds and uses thereof 卡尔约药物治疗公司 2018-05-11 CN disclosed
US-7468380-B2 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-12-23 US disclosed
WO-2008048914-A1 POLYCYCLIC COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-04-24 WO disclosed
US-20070004764-A1 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-01-04 US disclosed
US-7109219-B2 Nitrogen-containing aromatic derivatives EISAI CO., LTD. (JP) 2006-09-19 US disclosed
US-20050187236-A1 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187236-A1 Nitrogen-containing aromatic derivatives NR0B2, NR0B1, NR4A1 USP30 2064/4885MEN1 3535/4885KMT2A 986/4885
US-20070004764-A1 Nitrogen-containing aromatic derivatives NR0B2, NR0B1, NR4A1 USP30 2064/4885MEN1 3535/4885KMT2A 986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.